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National Laboratory of Solid State Microstructures and Department of Physics, Nanjing University, Nanjing, ChinaABSTRACT The tumor suppressor p53 plays a key role in the cellular response to various stresses. Most previous studies
have focused on either the nuclear or cytoplasmic proapoptotic functions of p53, ignoring the combination of both functions.
To explore how the two functions of p53 are coordinated in the DNA damage response via computer simulation, we construct
a model for the p53 network comprising coupled positive and negative feedback loops involving p53, Mdm2, and Akt, as well as
PUMA and Bax. In our model p53 is stabilized and accumulates in the nucleus and cytoplasm upon DNA damage. Nuclear p53
induces expression ofMdm2, PTEN, PUMA, and Bax. Cytoplasmic p53 is then released from the p53$Bcl-xL complex by PUMA
to activate Bax directly. We find that the switching between low and high protein levels underlies the decision between cell
survival and death. Moreover, a balance between the nuclear and cytoplasmic p53 levels and appropriate levels of Akt and
PUMA are required for reliable cell fate decision. Our results indicate that coordination of the transcription-dependent and -inde-
pendent activities of p53 is important in determining cellular outcomes. These findings advance our understanding of the mech-
anism for p53-mediated cellular responses and provide clues to p53-based cancer therapy.INTRODUCTIONThe tumor suppressor p53 is a central player in safeguarding
the integrity of the genome. It plays a key role in the cellular
response to various stresses including DNA damage,
hypoxia, and oncogene activation (1,2). In unstressed cells,
p53 levels are kept low by its negative regulator Mdm2 (3).
Upon DNA damage, p53 can be stabilized and activated to
induce cell cycle arrest, DNA repair, or apoptosis (2). De-
pending on the extent of DNA damage, cells either recover
to normal proliferation or undergo apoptosis; that is, a deci-
sion between life and death is made by p53 signaling path-
ways (2).
p53 performs its function primarily as a nuclear transcrip-
tion factor, regulating the expression of target genes to
induce diverse cellular outcomes (4,5). For example, p53
can promote apoptosis through transactivating proapoptotic
genes such as PUMA and Bax; such proapoptotic activity
of p53 is crucial for suppressing tumorigenesis (6–8). On
the other hand, apoptosis can be induced directly by the
transcription-independent activity of p53 in the cytoplasm
(9–11). Especially, p53 can activate Bax directly via tran-
sient protein-protein interactions (12).
Interestingly, the nuclear and cytoplasmic proapoptotic
activities of p53 can be well coordinated by PUMA in
response to genotoxic stress (13). Nuclear p53-inducible
PUMA can displace cytoplasmic p53 from its inhibitor
Bcl-xL so that p53 can activate Bax directly (12). Subse-
quently, mitochondrial outer membrane permeabilization
(MOMP), the release of cytochrome c, and activation of cas-
pase cascade can be induced to initiate apoptosis (14). Thus,Submitted June 10, 2010, and accepted for publication July 22, 2010.
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combined into one single activity. Nevertheless, a couple
of issues arise from the study of Chipuk et al. (13), including
how the cell fate is determined by such coordinated p53
activities.
Moreover, cellular responses to DNA damage are also
mediated by some prosurvival factors; among them, the
serine-threonine kinase Akt is a major player (15). Akt
promotes cell survival by suppressing the activities of proa-
poptotic proteins through phosphorylation (16). Thus, Akt
and p53 regulate cellular outcomes in opposite ways. In
fact, there exists a double-negative feedback loop among
p53, Akt, and Mdm2 (17).
The p53 response to DNA damage may exhibit various
modes, depending on cell and stress types (4). In an analog
mode, a high (low) level of p53 leads to cell death (survival)
in response to lethal (sublethal) DNA damage (2). By
contrast, p53 levels can exhibit a series of discrete pulses
in a digital mode (18). We and others have separately devel-
oped theoretical models to explore the mechanism for cell
fate decision mediated by p53 pulses (19–21). Nevertheless,
most previous studies center on either the nuclear or the
cytoplasmic activity of p53, whereas coordination of the
two functions of p53 is rarely investigated theoretically.
Especially, the role of PUMA in the p53-mediated cellular
response needs to be further clarified.
Motivated by the above considerations, here we develop
a model for the p53 network in response to DNA damage,
comprising the p53-Mdm2-Akt subnetwork as well as
PUMA and Bax. Using numerical simulations, we correlate
the temporal evolution of protein levels with the choice of
cell fate. We demonstrate that the subcellular distribution
of p53, the expression of PUMA and its affinity for Bcl-xL,
and Akt levels remarkably affect the DNA damage response.doi: 10.1016/j.bpj.2010.07.042
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plasmic activities of p53 by PUMA subserves making
optimal decisions. Our findings are consistent with experi-
mental observations, and theoretical predictions are experi-
mentally testable.
MODEL AND METHODS
This work is to clarify the mechanism for the response of HCT116 cells to
ultraviolet (UV) radiation (13). The schematic diagram of the model is pre-
sented inFig. 1.Ourmodel for thep53-Mdm2-Akt subnetwork is anextension
of Model Q3 in Wee and Aguda (22) by incorporating complex interactions
and subcellular distribution of p53 and Mdm2. There exists a negative feed-
back loop between p53 and Mdm2, in which nuclear p53 induces expression
ofMdm2 and nuclear Mdm2 promotes degradation of p53 (3). This negative
feedback is essential formaintaining low levels of p53 in unstressed cells. The
presence of DNA damage enhances the degradation of nuclear Mdm2 and
accumulation of p53. Moreover, there exists a positive feedback loop
involving p53, Akt, andMdm2. Nuclear p53 represses Akt activity indirectly,
whereas Akt promotes the nuclear translocation of Mdm2 to degrade p53
(23). As a phosphatase, p53-inducible PTEN promotes the transition from
PIP3 (Phosphatidylinositol 3,4,5-trisphosphate) to PIP2 (Phosphatidylinosi-
tol 4,5-biphosphate) (24,25). PIP3 is required for recruitment of Akt to the
plasma membrane, where Akt becomes phosphorylated. As a kinase, Akt
phosphorylates cytoplasmic Mdm2 and promotes its nuclear entry.
In our model, three forms of p53 are considered: p53n (nuclear p53), p53c
(inactive form of cytoplasmic p53, i.e., p53 in complex with Bcl-xL), and
p53c (active form of cytoplasmic p53, i.e., free p53). Three forms ofPIP3
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cytoplasmic Mdm2), and Mdm2cp (phosphorylated cytoplasmic Mdm2).
Two forms of cytoplasmic Akt are distinguished between Akt (inactive,
dephosphorylated form) and Aktp (active, phosphorylated form). Note
that activation of nuclear Akt can promote p53 stabilization in the response
of lymphoblasts to ionizing radiation (26). However, no evidence supports
the presence of this mechanism in HCT116 cells used by Chipuk et al. (13);
thus, the effects of nuclear Akt are not considered in our model.
The activity of cytoplasmic p53 is initially sequestered by Bcl-xL (12).
After DNA damage, p53 can be liberated from the p53$Bcl-xL complex
by PUMA because it has a higher affinity for Bcl-xL than p53 does (13).
In other words, it is PUMA that determines the status of cytoplasmic
p53, whereas the total PUMA level ([PUMA]T) is mainly controlled by
nuclear p53. Here, PUMA molecules that are able to release cytoplasmic
p53 are denoted by PUMA*, whereas those in complex with Bcl-xL are rep-
resented by PUMAin.
Free cytoplasmic p53 can activate Bax directly to induce apoptosis (12).
Here, we consider two forms of Bax: inactive Bax (Baxin) whose activity is
inhibited by the neutralization effects of Bcl-2, and active Bax (Bax*) that
can oligomerize and form lipid pores on the mitochondrial membrane to
induce MOMP (14). It is assumed that cytoplasmic p53 acts as an activator
to promote the conversion from the inactive to active form of Bax. p53 does
not form a stable complex with Bax; rather, they interact via the hit-and-run
mechanism, and the activation of Bax results from a conformational change
(27). The events after Bax activation are not characterized here. We simply
consider persistent activation of Bax as a marker of apoptosis induction.
The dynamics of the model are characterized by ordinary differential
equations, which are presented in the Appendix, and a set of standard
parameter values is listed in Table 1. Note that oscillations in p53 levelsPIP2
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FIGURE 1 Schematic diagram of the model for
the p53 network in response to DNA damage.
There exists a negative feedback loop between
p53 and Mdm2 and a double-negative one
involving p53, Akt, and Mdm2. Both the nuclear
and cytoplasmic forms of p53 and Mdm2 are
considered, whereas only the cytoplasmic forms
of other proteins are included. DNA damage
enhances the degradation of nuclear Mdm2, and
sustained activation of Bax induces apoptosis.
(Dot-dashed lines) p53-induced gene expression.
(Arrowed lines) Translocation of molecules or
transitions between proteins (promotion of which
is denoted by circle-headed lines).
Biophysical Journal 99(6) 1696–1705
A B
FIGURE 2 Temporal evolution of protein levels in response to DNA
damage. The initial stress level is 7.0 (A) or 5.2 (B). Each panel shows
time courses of the levels of p53n (shaded line), p53

c (dash-dotted line),
PTEN (dash-dot-dotted line), total PUMA (dashed line), and Bax* (solid
line). The extent of DNA damage (thin line) decreases linearly because
of the repair process. Depending on the initial stress level, the cell
undergoes apoptosis (A) or survives after DNA damage is fixed (B).
TABLE 1 A set of standard parameter values
Parameter Unit Value Parameter Unit Value
krep min
1 0.0055 kaktp min1 20
kp53n min
1 0.8 Jaktp mM 0.1
kp53c min
1 2 kaktdp mM=min 0.2
kdmp53n min
1 0.5 Jaktdp mM 0.4
Jdmp53n mM 0.01 kPIP3 mM=min 0.5
kdp53n min
1 0.04 JPIP3 mM 0.2
kp53i mM
1min1 0.3 kPIP2 min1 22
kp53a mM
1min1 3 JPIP2 mM 0.01
kp53a0 min
1 0.01 kPTEN mM=min 0.001
kdp53bx min
1 0.025 k
0
PTEN mM=min 0.07
kp53 mM=min 0.1 J2 mM 1.2
kdp53cs min
1 0.01 kdPTEN min1 0.018
kdmp53cs min
1 0.01 kB mM=min 0.2
Jdmp53cs mM 0.15 kdB min
1 0.1
km2n min
1 0.1 kpuma mM=min 0.0002
km2c min
1 1 k
0
puma mM=min 0.16
kdm2n min
1 0.01 J3 mM 1.2
kdm2n0 min
1 0.04 kdpuma min1 0.05
km2 mM=min 0.018 kpumai mM
1min1 0.2
k
0
m2 mM=min 0.024 kpumaa0 min
1 0.1
J1 mM 1.6 kbax mM=min 0.0001
km2dp mM=min 0.2 k
0
bax mM=min 0.06
Jm2dp mM 0.05 J4 mM 1.2
km2p min
1 10 kdbax min1 0.01
Jm2p mM 0.3 kbaxa mM
1min1 2
kdm2c min
1 0.01 kbaxi min1 0.5
kdm2cp min
1 0.01
1698 Pu et al.were mainly observed in cellular responses to ionizing radiation (18).
Because p53 levels exhibit switchlike behaviors in Chipuk et al. (13), we
will not investigate the oscillatory dynamics of p53 in this work.
Considering the cooperativity of the tetrameric form of p53 as a transcrip-
tion factor, the rate of p53-induced gene expression is typically character-
ized by a fourth-order Hill function of p53 level (20,28). To our
knowledge, few models were constructed to describe the p53 response to
UV radiation. With limited experimental data available, we still assume
the Hill coefficient to be 4. Moreover, our simulation results indicate that
the conclusions drawn here qualitatively hold true when changing the value
of the coefficient. The Michaelis-Menten kinetics are used to characterize
the reactions involving phosphorylation and dephosphorylation. Mdm2-tar-
geted proteasomal degradation of p53 also obeys the Michaelis-Menten
kinetics, whereas the basal degradation of proteins is modeled as first-order
reactions.
It is noted that cyclobutane pyrimidine dimers (CPDs) are the main form
of DNA damage induced by UVB (one kind of UV light as used by Chipuk
et al. (13)), and on average 4.4 CPDs are produced per Mbp per J/m2 UVB
(29). Given the average length of human DNA (~6 109 bp), it is estimated
that ~2.6  105 CPDs per cell can be produced at 10 J/m2 UVB. We divide
the initial number of CPDs produced at each dose of UVB by 2.6 105 and
denote it by DNA0dam, which is used to characterize the initial extent of DNA
damage. For the sake of simplicity, we assume that DNA damage is repaired
at a constant rate and that the degradation rate of Mdm2n increases linearly
with the extent of DNA damage.
Several other assumptions are made to simplify the model:
First, the total amount of Bcl-xL is assumed to be constant, because it
was shown experimentally that Bcl-xL expression remains unchanged after
UV treatment in HCT116 cells (13).
Second, the production and degradation of Akt are very slow, with its
normal half-life being tens of hours, whereas the (de)phosphorylation of
Akt is much faster. It was experimentally shown that even after radiation,
Akt levels remain nearly unchanged (17). Thus, the total Akt level
([Akt]T) is assumed to be constant.Biophysical Journal 99(6) 1696–1705Third, the total amount of PIP2 and PIP3, [PIP]T, is also assumed to be
constant.
Fourth, although cell cycle arrest is not explicitly modeled here, it is
implicitly assumed to appear immediately upon DNA damage.
Integration of differential equations is performed using a fourth-order
Runge-Kutta method with a time step of 0.01 min. On each simulation trial,
the initial concentration of each species is set to its lower stable steady-state
value. The values of [Akt]T and [PIP]T are set to 0.5 mM and 1 mM, respec-
tively, unless specified otherwise.RESULTS
p53-mediated cell fate decision
We first illustrate how the p53 network responds to different
levels of DNA damage. Upon severe damage, p53n level first
increases because of enhanced degradation of Mdm2
(Fig. 2 A). The levels of Mdm2, PTEN, PUMA, and Bax
then rise as a result of nuclear p53-induced gene expression.
PTEN inhibits the nuclear entry of Mdm2, resulting in
a further increase in p53n level. Thus, the total levels of
PUMA and Bax quickly rise in a switchlike manner.
PUMA liberates cytoplasmic p53 from its interaction with
Bcl-xL, leading to an increase in p53c level. Subsequently,
p53c activates Bax, and the concentration of Bax* rises to
a high level with a marked delay. Notably, the levels of these
proteins are maintained around their maxima for a long
time. According to the experimental observations that Bax
induces MOMP and release of cytochrome c within
15 min after its activation (30,31), we assume that apoptosis
will be initiated once Bax* level remains above some
threshold (~2.1 mM, see below) for >30 min. Thus, the
cell will undergo apoptosis in this case. By contrast, when
DNA damage is slight or moderate, the amounts of those
proteins rise gradually and then drop quickly to basal levels
(Fig. 2 B). In this case, DNA damage can be fixed within
a relatively short period and the cell survives. Thus, tran-
sient activation of Bax cannot induce apoptosis compared
with its sustained activation.
It is noted that those proteins always return to their basal
levels after DNA repair in our model. This is because we did
A B
FIGURE 4 Temporal evolution of the levels of p53n (A) and Bax* (B) in
response to DNA damage with DNA0dam ¼ 4.0 (dashed lines), 5.2 (solid
lines), or 6.0 (dash-dotted lines).
Coupled p53 Activities Mediate Cell Fate 1699not consider the effects of downstream apoptotic events on
DNA repair-related proteins and p53. Actually, the activa-
tion of caspases after apoptosis initiation may cleave
a number of proteins including the components of DNA
repair machinery and p53 (32). We did not model these
complicated effects, but only consider sustained activation
of Bax as a marker of apoptosis induction.
We then systematically explore the dependence of cell fate
on the initial stress level. The first step is to analyze the
steady-state solution of the model as a function of DNA
damage level, DNAdam. p53n and Bax* levels exhibit bist-
ability over the same range between 0.64 and 4.38 (Fig. 3).
When moving rightwards across the upper threshold along
the lower stable branch, p53n and Bax* levels jump to the
higher stable state, and their values change slightly with
further increasing DNAdam. When moving leftwards across
the lower threshold along the higher stable branch, p53n
and Bax* levels drop to very small values from 1.22 and
2.11 mM, respectively. Such switchlike activation of Bax
has previously been proposed (33). As will be seen later,
the switching between the lower and higher states underlies
the decision between cell life and death.
Actually, the extent of DNA damage decreases with the
progression of DNA repair rather than being kept fixed. If
Bax* level is larger than 2.1 mM only transiently, no
apoptosis is induced. It is still necessary to determine cell
fates based on the temporal evolution of protein levels.
The simulation results for various stress levels are displayed
in Fig. 4. The amounts of proteins can be maintained in
the high-level state for a long period or be close to 0; accord-
ingly, cells either die or live. Nuclear p53 levels are kept low
in response to mild DNA damage (say DNA0dam ¼ 4.0)
(Fig. 4 A), and little Bax is activated (Fig. 4 B). Thus, the
cell survives after DNA damage is repaired. With moderate
DNA damage (e.g., DNA0dam ¼ 5.2), both nuclear p53 and
Bax are activated transiently, and such transient activation
is insufficient to reach the threshold for apoptosis induction.
At high stress levels (say DNA0dam ¼ 6.0), both p53n andFIGURE 3 Steady-state bifurcation diagram of the levels of p53n (shaded
curve) and Bax* (black curve) as a function of stress level, DNAdam. (Solid
and dashed lines) Stable and unstable states, respectively.Bax* levels are kept around their maxima for a long time,
and thus apoptosis is initiated. Therefore, the choice of
cell fate is associated with the switching between low and
high protein levels. With the standard parameter values
used (see Table 1), cells survive when DNA0dam < 5.3
(i.e., the dose of UV is smaller than 53 J/m2) or undergo
apoptosis otherwise. This is consistent with the experi-
mental observations (13).Role of PUMA in cell fate decision
It has been experimentally shown that PUMA can couple the
nuclear and cytoplasmic proapoptotic functions of p53 (13).
Here, we systematically explore the role of PUMA in cell
fate decision.
First, we investigate the importance of PUMA in
apoptosis induction by changing the value of the maximal
p53-inducible synthesis rate of PUMA, k0puma. Note that
the total Bax level is nearly independent of k0puma. Differ-
ently, the total PUMA level depends remarkably on k0puma
(Fig. 5 A). For small k0puma (say 0.068 mM/min), there is
only weak expression of PUMA, while a small fraction of
Bax is transiently activated (Fig. 5 B); no apoptosis is trig-
gered. For moderate k0puma (e.g., 0.15 mM/min), the amount
of PUMA is sufficient to evoke significant activation of Bax,
and apoptosis is initiated. For large k0puma (say 0.3 mM/min),
PUMA level rises remarkably while Bax* level varies
slightly, compared with the case of k0puma ¼ 0.15. Therefore,A B
FIGURE 5 Effect of PUMA expression on apoptosis induction.
Temporal evolution of [PUMA]T (A) and Bax* level (B) with k
0
puma ¼
0.068 (dashed lines), 0.15 (solid lines), or 0.30 mM/min (dash-dotted lines).
The initial DNA damage level is 6.0.
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sion makes cells resistant to stress. Presumably, low levels
of PUMA may result from low binding affinity of p53 to
the promoter of PUMA. Actually, weak PUMA expression
may be an important prognostic marker for some human
cancers (34,35).
The activation of Bax requires that PUMA bind Bcl-xL to
replace cytoplasmic p53 in addition to high-level expression
of PUMA and Bax. To see this clearly, we systematically
change the value of kp53a, which characterizes the binding
affinity of PUMA to Bcl-xL. When kp53a is small (say
0.01 mM1 min1), a small fraction of cytoplasmic p53 is
released from Bcl-xL. Thus, only a small amount of Bax
is transiently activated, and no apoptosis is initiated even
in severely damaged cells (Fig. 6 A). When kp53a is large
enough, both cytoplasmic p53 and Bax are activated to
induce apoptosis. On the other hand, for very large kp53a
(e.g., 15 mM1 min1), a large fraction of cytoplasmic
p53 is released from Bcl-xL, and Bax* level is high enough
to initiate apoptosis even at moderate stress intensityA
B
C D
FIGURE 6 Effect of binding affinity of PUMA to Bcl-xL on cell fate
decision. (A and B) The initial stress level is 6.0 (A) or 5.2 (B). Temporal
evolution of the levels of p53c (left column) and Bax* (right column)
with kp53a ¼ 0.01 (dashed lines), 3 (solid lines), or 15 mM1 min1
(dash-dotted lines). (C) For each given k0puma and initial stress level,
there exists a minimum of kp53a for apoptosis induction, kp53ac. The panel
shows kp53ac versus k
0
puma with DNA
0
dam ¼ 6.0 (circle) or 5.2 (cross).
(D) Temporal evolution of [PUMA]T (dash-dotted line), p53

c (dashed line),
and Bax* (solid line) levels with k53i ¼ 0.003 mM1 min1, k0puma ¼ 0,
and DNA0dam ¼ 6.0.
Biophysical Journal 99(6) 1696–1705(Fig. 6 B). Therefore, appropriate affinity of PUMA for
Bcl-xL is crucial for optimal cell fate decision.
The results for the case of small kp53a are consistent with
the experimental observation by Chipuk et al. (13). They
used mutant Bcl-xL that binds p53 rather than PUMA to
make cells resistant to p53-induced apoptosis irrespective
of PUMA expression. By analogy, we propose that mutation
in PUMAmay also impair its preferential binding to Bcl-xL,
undermining its ability to release p53 from Bcl-xL. That is,
the affinity of PUMA for Bcl-xL affects cellular sensitivity
to apoptotic signals. A higher affinity makes cells more
prone to die, whereas a lower affinity makes cells more
resistant to DNA damage. It would be intriguing to test
this experimentally.
The above results suggest that a tradeoff between cell life
and death requires appropriate values of kp53a and k
0
puma. To
make this point clear, we further investigate the combina-
tory effect of kp53a and k
0
puma on cellular outcomes. For
a fixed initial stress level, we calculate the minimum of
kp53a for apoptosis induction at each k
0
puma and denote it
by kp53ac. kp53ac decreases with increasing k
0
puma (Fig. 6 C).
For a larger synthesis rate of PUMA, weaker binding affinity
of PUMA to Bcl-xL is required to trigger apoptosis, and
vice versa. That is, the p53-induced expression of PUMA
and the release of p53 from Bcl-xL by PUMA complement
each other in apoptosis induction. On the other hand, for
small k0puma, kp53ac becomes much smaller in response to
severe DNA damage compared with the response to mild
DNA damage. Therefore, both the expression of PUMA
and its affinity for Bcl-xL should be within a proper range
so that cells can survive after repairable DNA damage is
fixed or undergo apoptosis otherwise. Together, both the
nuclear and cytoplasmic functions of p53 are significant in
cell fate decision, and PUMA acts as an important coordi-
nator.
The interaction between p53 and Bcl-xL may also be dis-
rupted owing to some mutation in Bcl-xL or the presence of
small-molecule inhibitors such as pifithrin-m (PFT-m).
PFT-m can remarkably reduce the binding affinity of p53
to Bcl-xL but has no effect on its transcriptional function
(36). This implies that PFT-m may promote accumulation
of free cytoplasmic p53. We mimic this effect of PFT-m
by decreasing the inactivation rate of p53c , kp53i, from
0.3 to 0.003 mM1 min1 and setting k0puma ¼ 0. At high
DNA damage levels, despite very low PUMA level, most
cytoplasmic p53 molecules are free from the inhibition of
Bcl-xL, resulting in sustained activation of Bax (Fig. 6 D).
This is consistent with the experimental observation that
p53 can induce apoptosis in PUMA-deficient Bcl-xL/
cells (13). Therefore, our results verify that liberation of
cytoplasmic p53 from Bcl-xL is a critical event in the direct
activation of Bax by p53. Our results also suggest that PFT-
m may be able to reactivate the proapoptotic function of
cytoplasmic p53 in PUMA-deficient tumor cells.
A B
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We have revealed the role of PUMA in coupling the nuclear
and cytoplasmic functions of p53. Here, we further investi-
gate the effect of subcellular distribution of p53 on cell fate
decision by changing its nuclear export rate kp53n. We calcu-
late the maximal protein levels on each simulation trial;
they exhibit different dependence on kp53n (Fig. 7 A).
Clearly, [p53c]max rises with increasing kp53n when
kp53n % 3.1 min
1, whereas [p53n]max and [PUMA*]max
decrease monotonically. Differently, [Bax*]max exhibits
a nonmonotonic behavior. [PUMA]T and [Bax]T are mainly
determined by [p53n], while [Bax*] remarkably depends on
[p53c] and [Bax]T. Lack of nuclear p53 greatly reduces the
expression of Bax, while lack of free cytoplasmic p53
suppresses the activation of Bax. Thus, [Bax*] depends on
both the nuclear and cytoplasmic levels of p53; [Bax*]max
reaches a maximum at kp53n ~ 1.28. When kp53n > 3.1, the
amount of free cytoplasmic p53 decreases with increasing
kp53n because of very low PUMA* level, and [Bax*]max is
smaller than the threshold for apoptosis induction. That is,
excessive nuclear export of p53 makes cells resistant to
lethal DNA damage. This is consistent with the experi-
mental observations in neuroblastoma cells, where remark-
able exclusion of p53 from the nucleus leads to deficiency in
apoptosis induction (37,38). Similarly, when kp53n < 0.16,
[Bax*]max is also smaller than the threshold for apoptosis
induction. Thus, a balance between the nuclear and cyto-
plasmic p53 levels is crucial for the full activation of
apoptosis.
For each kp53n, there exists a minimal extent of DNA
damage for apoptosis induction, DNAcdam, which takes
a minimum at kp53n ~ 0.2 min
1 (Fig. 7 B). For kp53n <
0.13, a small amount of cytoplasmic p53 is insufficient to
activate Bax to induce apoptosis when DNA0dam < 10.
Similarly, for kp53n > 3.2, a low level of nuclear p53 is
unable to induce enough PUMA and Bax, and no apoptosis
is triggered when DNA0dam < 10. In the above cases, cells
become resistant to apoptosis. By contrast, for 0.16 %
kp53n % 0.68, apoptosis can be induced in response toA B
FIGURE 7 Effect of subcellular localization of p53 on cell fate decision.
(A) The maximal levels of p53n (shaded line), p53

c (dashed line), PUMA*
(dash-dotted line), and Bax* (solid line) versus the nuclear export rate of
p53, kp53n. The initial stress level is 6.0. (B) The minimal extent of DNA
damage for apoptosis induction, DNAcdam, versus kp53n.DNA damage with DNA0dam > 5. Together, we conclude
that excessive accumulation of p53 in either compartment
makes cells resistant to apoptotic signals, and both the
nuclear and cytoplasmic activities of p53 are indispensable
for reliable cell fate decision. This awaits experimental vali-
dation.Akt acting as a gatekeeper for apoptosis
induction
While coordination of the nuclear and cytoplasmic activities
of p53 is vital to cell fate decision, cross-talk between p53
and Akt also mediates cellular responses. As mentioned
above, p53 and Akt antagonize each other through a
double-negative feedback. Specifically, Akt can counteract
the effect of p53 on apoptosis induction by promoting the
nuclear translocation of Mdm2. By contrast, p53-inducible
PTEN can suppress Akt activity to enhance the proapoptotic
function of p53.
Fig. 8 A shows the steady-state bifurcation diagram of
p53n and Aktp levels versus DNAdam. They share the same
bistability range but exhibit totally opposite switching
behaviors. In fact, when Aktp level is in the upper branch,
p53n level is in the lower branch, and vice versa. This is
because either p53 or Akt achieves self-accumulation by in-
hibiting the other. Indeed, the increase in DNAdam promotes
p53n accumulation, and the subsequent deactivation of Akt
further enhances the accumulation of p53n.
The effect of Akt on cell fate decision is explored by
varying the total Akt level. We first study the bifurcation
diagrams of Bax* level versus DNAdam for various [Akt]T
(Fig. 8 B). For small [Akt]T (e.g., 0.15 mM), the thresholdC D
FIGURE 8 Effect of Akt on cell fate decision. (A) Steady-state bifurca-
tion diagram of p53n (black line) and Aktp (shaded line) levels versus the
extent of DNA damage with [Akt]T ¼ 0.5 mM. (B) Bifurcation diagram
of Bax* level with [Akt]T ¼ 0.15 (shaded line), 0.5 (black line), or 5 mM
(dash-dot-dotted line). (C and D) Time courses of Bax* (black lines) and
Aktp (shaded lines) levels with [Akt]T ¼ 0.15 (dashed lines) or 0.5 mM
(solid lines) at DNA0dam ¼ 5.2 (C); with [Akt]T ¼ 0.5 (solid lines) or
5 mM (dashed lines) at DNA0dam ¼ 6.0 (D).
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1702 Pu et al.value of DNAdam for Bax activation is relatively small, and
the switching is irreversible. Once Bax is activated, it
remains active. The threshold value gets smaller with further
decreasing [Akt]T, and cells become more sensitive to DNA
damage, so that even mild damage can induce apoptosis.
When [Akt]T is within the range of 0.18~4.8 mM, Bax*
level exhibits reversible bistability, and the bistability range
shrinks with increasing [Akt]T. For large [Akt]T (say
5.0 mM), Bax* level exhibits monostability and varies
sigmoidally with DNAdam. Only when DNAdam is large
enough can Bax* level be kept at large values. In sum,
Bax* levels exhibit irreversible and reversible bistability
and monostability, respectively, with increasing [Akt]T.
Next, we show the temporal evolution of Aktp and Bax*
levels for various [Akt]T values at distinct stress intensity. In
unstressed cells, most Akt molecules are phosphorylated
and activated, whereas levels of the proapoptotic proteins
are kept low. Upon DNA damage, p53n accumulates and
PTEN is expressed, whereas Akt phosphorylation is
reversed. If DNA damage is repairable, Bax* abundance
drops to basal levels and Akt is rephosphorylated after tran-
sients (Fig. 8 C). With [Akt]T reduced, however, even mild
DNA damage can induce apoptosis. That is, lack of Akt
makes cells rather sensitive to DNA damage, and accidental
stress may threaten cell survival. For example, only a small
amount of Akt has been detected in brain samples from
Huntington patients, leading to neuronal dysfunction and
death (39). In the case of severe DNA damage, a high
Bax* level is maintained, whereas most Akt molecules are
dephosphorylated (Fig. 8 D). Consequently, apoptosis is
induced. With increased [Akt]T, however, even severely
damaged cells may escape from apoptosis. Thus, cells
become resistant to DNA damage, which greatly increases
the risk of tumorigenesis. Our results are consistent with
the role of Akt as an oncoprotein (15). Together, Akt levels
should be controlled to guarantee the balance between cell
survival and death.SUMMARY AND DISCUSSION
We have characterized coordination between the nuclear
and cytoplasmic p53 pathways in response to DNA damage.
In our model, both the negative feedback loop between p53
and Mdm2 and the positive one involving p53, Akt and
Mdm2 are considered. Consequently, the switching between
low and high protein levels underlies the decision between
cell survival and death. Upon DNA damage, destabilization
of Mdm2 leads to accumulation of p53 in the nucleus and
cytoplasm, as well as deactivation of Akt by dephosphoryla-
tion. Nuclear p53 induces expression of Mdm2, PTEN,
PUMA, and Bax. Subsequently, cytoplasmic p53 is released
from Bcl-xL by PUMA to activate Bax directly; sustained
activation of Bax induces apoptosis. Depending on the
initial stress intensity, cells either survive or die. Both the
nuclear and cytoplasmic functions of p53 are important forBiophysical Journal 99(6) 1696–1705cell fate decision; deficiency of p53 in either compartment
makes stressed cells resistant to death signals. Moreover,
Akt can suppress p53 activity, and its appropriate levels
contribute to the balance between cell survival and death.
p53 is primarily a nuclear protein, acting as a transcription
factor (4). Cytoplasmic sequestration of p53 may interfere
with its transcriptional function (40). Indeed, excessive accu-
mulation of cytoplasmic p53 appears to promote inactivation
of p53 in tumors (37,38). However, cytoplasmic p53 can also
activate Bax directly through a transcription-independent
mechanism (11,12), and PUMA can couple the nuclear and
cytoplasmic functions of p53 in response to genotoxic stress
(13). Here, we further demonstrate that such coordinated p53
activities contribute to cell fate decision; thus, the limitation
associated with individual p53 pathways may be overcome.
For example, it was reported that the transcription-indepen-
dent p53 pathway is activated to induce apoptosis rather
than cell cycle arrest (41) and that the transcription-depen-
dent pathway can only initiate cell cycle arrest in some
tissues (42). By contrast, coordination of the transcription-
dependent and -independent functions of p53 subserves
making reliable decisions by integrating diverse signals.
Cytoplasmic p53 behaves as an activator, like the BH3-
only proteins Bid and Bim, activating Bax directly, whereas
mitochondrial p53 can act as an enabler to activate Bax indi-
rectly by releasing Bax from its inhibitor (11). The binding
of cytoplasmic p53 to Bcl-xL is antiapoptotic (13), whereas
that of mitochondrial p53 to Bcl-xL is proapoptotic (43).
Moreover, it has recently been reported that the small mole-
cule PFT-m can inhibit the proapoptotic activity of mito-
chondrial p53 by reducing its affinity for Bcl-xL (36),
whereas our results suggest that PFT-m may enhance the
proapoptotic function of cytoplasmic p53. Thus, with PFT-
m as a probe, the role of p53 in apoptosis induction can be
distinguished between an enabler and an activator, which
may allow for pertinent treatment of some cancers. It would
also be intriguing to explore the possible coordination
among nuclear, cytoplasmic, and mitochondrial p53 path-
ways in response to stresses.
Our results are in good agreement with experimental
observations. Chipuk et al. (13) have demonstrated in muta-
tion experiments on Bcl-xL that the release of cytoplasmic
p53 from Bcl-xL by PUMA is required to induce apoptosis.
In our simulations, decreasing the binding affinity of PUMA
to Bcl-xL does make cells more resistant to DNA damage.
Furthermore, decreasing the synthesis rate of PUMA has
a similar effect. Thus, modulating the proapoptotic activity
of PUMA is an efficient way to regulate apoptosis develop-
ment. Actually, deletion of PUMA abrogates p53-induced
apoptosis and greatly increases the risk of tumorigenesis
(34,35). Given the potential role of some small-molecule
inhibitors, like PFT-m, in liberating cytoplasmic p53 from
its inhibitor, a possible strategy for tumor therapy is to
utilize them to reactivate or potentiate the proapoptotic
function of cytoplasmic p53.
Coupled p53 Activities Mediate Cell Fate 1703The p53 dynamics are actually cell-, tissue-, and stress-
dependent in the DNA damage response (4). To our knowl-
edge, oscillatory p53 dynamics in response to UV radiation
were suggested only in one experiment (44), with a period
(15 ~20 h) much longer than the typical one (5 ~7 h) in
cellular responses to ionizing radiation (18,45). No
evidence suggests the existence of p53 oscillations in the
experiment by Chipuk et al. (13). Nevertheless, it is still
worth experimentally exploring whether p53 oscillations
exist in the UV response of other cells. Undoubtedly, the
negative feedback between p53 and Mdm2 is the basis of
p53 oscillations. However, it was proposed that the positive
feedback loop involving p53, PTEN, Akt, and Mdm2 can
terminate oscillations induced by the p53-Mdm2 loop and
enable p53 abundance to rise to high levels (46). In our
model, p53 and PTEN are activated almost simultaneously.
Thus, the positive feedback loop becomes dominant over
the negative one, and p53 levels show a switchlike
behavior.
Akt levels should be controlled within a proper range.
Either deficiency or excessive expression of Akt may
destroy the balance between cell life and death, leading to
improper cellular outcomes. Overexpression of Akt has
been observed in several cancer cell lines (15), whereas
lack of Akt makes cells ultrasensitive to stress signals and
leads to diseases in animals and humans (39). Moreover,
for the sake of simplicity, only the role of Akt in suppressing
accumulation of nuclear p53 is considered in our model. In
fact, Akt can also inhibit apoptosis through repressing the
activities of other proapoptotic factors such as Bad and
several caspases (47). Thus, a more detailed model may
be helpful to thoroughly explore the effect of Akt on cell
fate decision.
It is worth noting that a couple of aspects of p53 regula-
tion are not considered in our model. First, here we include
only two feedback loops involving p53. The p53-Mdm2
negative feedback loop is the core of p53 regulation (48),
and the p53-Akt-Mdm2 positive feedback loop is significant
for the p53-mediated decision between cell life and death
(22). Nevertheless, there also exists another negative feed-
back loop between p53 and Wip1, in which p53-induced
Wip1 decreases the level and activity of p53 by dephosphor-
ylating p53, Mdm2, ATM, and Chk1 (49). This loop may act
as a gatekeeper for the p53-Mdm2 loop and set a barrier
for p53 activation and apoptosis induction. Presumably,
adding this loop to our model would increase the threshold
for apoptosis induction, but not qualitatively change our
main conclusions. Second, we did not explicitly consider
posttranslational modifications of p53, which may have an
important role in cell fate decision (4). For example, the
phosphorylation of p53 at Serine 46 promotes expression
of the proapoptotic gene p53AIP1 (50). Moreover, some
posttranslational modifications of p53 can affect its subcel-
lular localization (4). Thus, an extended model should be
constructed to explore these effects in the future.In this work we explored the mechanism for cell fate
decision after DNA damage based on the nuclear and cyto-
plasmic p53 pathways. Our study points to the central roles
of p53, PUMA, and Akt. First, p53 is stabilized and accumu-
lates in both the nucleus and cytoplasm upon DNA damage,
and then induces different cellular outcomes including
survival and apoptosis. Second, PUMA acts as a coordinator
coupling the nuclear and cytoplasmic activities of p53.
Dysfunction of PUMA may greatly increase the risk of
tumorigenesis or lead to unnecessary death of repairable
cells. Third, Akt can modulate cellular responses, acting
as a gatekeeper for p53-dependent apoptosis. An appro-
priate Akt level is vital to reliable cell fate decision. These
results enrich the understanding of how the p53 network
responds to various stresses and may provide clues to p53-
based cancer therapy.APPENDIX
The dynamic equations of the model are presented as follows:
dDNAdam
dt
¼ krepqðDNAdamÞ (1)
d½p53n
dt
¼ kp53n½p53n þ kp53c

p53c

 kdmp53n½Mdm2n ½p53n
p53n
 þ Jdmp53n
 kdp53n½p53n (2)
d½p53 ,Bcl-xL
dt
¼ kp53i

p53c
½Bcl-xL
 kp53a½PUMA½p53 ,Bcl-xL
 kp53a0½p53 ,Bcl-xL
 kdp53bx½p53 ,Bcl-xL (3)
d

p53c

dt
¼ kp53 þ kp53n½p53n  kp53c

p53c

þ kp53a½PUMA½p53 ,Bcl-xL
þ kp53a0½p53 ,Bcl-xL
 kp53i

p53c
½Bcl-xL  kdp53csp53c
 kdmp53cs½Mdm2c

p53c


p53c
 þ Jdmp53cs (4)
d½Mdm2n
dt
¼ km2n½Mdm2n þ km2c

Mdm2cp

 kdm2n½Mdm2n  kdm2n0  DNAdam
 ½Mdm2n (5)Biophysical Journal 99(6) 1696–1705
1704 Pu et al.d½Mdm2  0 ½p53 4c
dt
¼ km2 þ km2 n½p53n4 þ J41
þ km2dp

Mdm2cp


Mdm2cp
 þ Jm2dp
 km2p

Aktp
 ½Mdm2c
Mdm2c
 þ Jm2p
 kdm2c½Mdm2c (6)
d

Mdm2cp

dt
¼ km2n½Mdm2n  km2c

Mdm2cp

þ km2p

Aktp
 ½Mdm2c
Mdm2c
 þ Jm2p
 km2dp

Mdm2cp


Mdm2cp
 þ Jm2dp
 kdm2cp

Mdm2cp

(7)
d

Aktp

dt
¼ kaktp½PIP3 ½Akt
Akt
 þ Jaktp  kaktdp

Aktp


Aktp
 þ Jaktdp
(8)
d½PIP3
dt
¼ kPIP3 ½PIP2½PIP2 þ JPIP3
 kPIP2½PTEN ½PIP3½PIP3 þ JPIP2 (9)
d½PTEN
dt
¼ kPTEN þ k0PTEN
½p53n4
½p53n4 þ J42
 kdPTEN½PTEN
(10)
d½Bcl-xLT
dt
¼ kB  kdB½Bcl-xLT (11)
d½PUMAT
dt
¼ kpuma þ k0puma
½p53n4
½p53n4 þ J43
 kdpuma½PUMAT
(12)
d½PUMA ,Bcl-xL
dt
¼ kp53a½PUMA½p53 ,Bcl-xL
þ kpumai½PUMA½Bcl-xL
 kpumaa0½PUMA ,Bcl-xL (13)
d½BaxT
dt
¼ kbax þ k0bax
½p53n4
½p53n4 þ J44
 kdbax½BaxT (14)Biophysical Journal 99(6) 1696–1705d½Bax   
dt
¼ kbaxa p53c ½Baxin  kbaxi½Bax  (15)
½AktT ¼

Aktp
 þ ½Akt (16)
½PIPT ¼ ½PIP3 þ ½PIP2 (17)
½Bcl-xLT ¼ ½Bcl-xL þ ½p53 ,Bcl-xL
þ ½PUMA ,Bcl-xL (18)
½PUMAT ¼ ½PUMA þ ½PUMA ,Bcl-xL (19)
½BaxT ¼ ½Bax þ ½Baxin (20)
qðxÞ ¼

1 xR0
0 x < 0
(21)
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